Journal article
Three Decades of Autologous Stem Cell Transplantation for Myeloma; Trends in Early Mortality and Survival
Abstract
Abstract
Introduction: Outcomes in multiple myeloma have significantly improved in recent times owing to the availability of newer more effective therapies. Autologous stem cell transplantation (ASCT) has been used for over three decades to treat multiple myeloma. We aimed to evaluate the outcome of patients receiving ASCT at our institution between 1990 and 2015.
Authors
Sidiqi MH; Aljama MA; Dispenzieri A; Muchtar E; Buadi FK; Warsame R; Lacy MQ; Dingli D; Leung N; Gonsalves WI
Journal
Blood, Vol. 132, No. Supplement 1,
Publisher
American Society of Hematology
Publication Date
November 29, 2018
DOI
10.1182/blood-2018-99-113665
ISSN
0006-4971